SymbolCERS
NameCERUS CORP
SectorTECHNOLOGY
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
Address1220 CONCORD AVENUE, CONCORD, CA 94520
Telephone9252886000
Fax
Email
Websitehttps://www.cerus.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001020214
Description

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Additional info from NASDAQ:
Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

2026-05-05 22:31

Jayaraman Vivek K 🔴 sold 16.7K shares of CERUS CORP (CERS) at $3.00 Transaction Date: May 01, 2026 | Filing ID: 206993

Read more
2026-05-01 20:08

📋 RICHARD J BENJAMIN (Officer) plans to sell 76K shares of CERUS CORPORATION (at $2.82 each, total $215K) Filed: May 01, 2026 | ID: 003893

Read more
2026-05-01 20:07

📋 VIVEK K JAYARAMAN (Officer) plans to sell 17K shares of CERUS CORPORATION (at $3.00 each, total $50K) Filed: May 01, 2026 | ID: 003891

Read more
2026-04-30 20:01

Cerus Corporation - Cerus Corporation Announces First Quarter 2026 Financial Results

Read more
2026-04-30 20:01

Cerus Corporation Announces First Quarter 2026 Financial Results

Read more
2026-04-27 12:00

Cerus Corporation - Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Read more
2026-04-27 12:00

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Read more
2026-04-22 13:02

New Form ARS - CERUS CORP <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001020214-26-000013 <b>Size:</b> 1 MB

Read more
2026-04-22 13:01

New Form DEF 14A - CERUS CORP <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001020214-26-000011 <b>Size:</b> 6 MB

Read more
2026-04-21 20:21

(99% Neutral) CERUS CORP (CERS) Announces Executive Departure

Read more